High versus low dose cyclosporine-A, after allogeneic marrow transplantation in leukemia: Long-term follow-up of a randomized study
Author:
Affiliation:
1. Istituto di Ematologia, Fondazione Policlinico Universitario A Gemelli, Universita’ Cattolica; Roma Italy
2. Divisione di Ematologia; IRCCS AOU San Martino IST; Genova Italy
Funder
Associazione Italiana Ricerca contro il Cancro Milano, Italy; FARITMO Genova
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25131/fullpdf
Reference12 articles.
1. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation. III. Prevention and treatment of relapse after allogeneic transplantation;Lima;Biol Blood Marrow Transplant.,2014
2. Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia;Clift;Blood.,1998
3. Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia;Bortin;Science.,1973
4. Antileukemic effect of graft versus host disease: contribution to improved survival after allogeneic marrow transplantation;Weiden;N Engl J Med.,1981
5. Graft versus leukemia reactions after bone marrow transplantation;Horowitz;Blood.,1990
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. How to Run a Successful Transplant Program in Older Patients with Myeloid Malignancies;Transplantation and Cellular Therapy;2024-08
2. Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin;Scientific Reports;2023-12-20
3. Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy;International Journal of Hematology;2023-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3